The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Showing 126 Results
National Pharmaceutical Council Appoints John M. O’Brien as President and CEO
Veteran drug pricing and health policy expert John M. O’Brien, Pharm.D., MPH, has been appointed as president and chief executive officer of the National Pharmaceutical Council, effective June 1,…
National Pharmaceutical Council Names Dr. Robert Dubois as Interim President and CEO
As interim president and CEO, Dr. Robert Dubois plans to focus on two priorities: continuing to leverage NPC's ongoing evidence-based research, partnerships and education, and preparing for future…
NPC Announces Departure of President and CEO Dan Leonard
Dan Leonard is leaving as head of the National Pharmaceutical Council, effective Sept. 4.
National Pharmaceutical Council and Duke-Margolis Center for Health Policy Announce New Health Policy Fellow
Dr. Salama Freed has been named NPC/Duke-Margolis Health Policy Fellow for 2020-22.
Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair
NPC announced that Blasine Penkowski, MBA, Chief Strategic Customer Officer of Johnson & Johnson Health Care Systems Inc., has been elected Chair of NPC’s Board of Directors for 2019-2020.
Celgene EVP Richard Bagger Elected National Pharmaceutical Council Board Chair
The NPC Board of Directors has named Celgene EVP Richard Bagger as Chairman for 2018-19.